___

• 1- Ghidini A. : Idiopathic fetal growth restriction: a pathophysiılogic approach. Obstet Gynecol Surv 51(6) :376-382, 19962- Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972; 1: 177–1913- Kaufman Et Al. Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia Bıology Of Reproductıon 69, 1–7 (2003)4- Dekker GA. Sibai BM. Low- dose apirin in the prevention of pre-eclampsia and fetal growth retardation: rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993; 168:214-2275- Renkin EM. Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol 985;58:315–3256- Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427–4517- van Hinsbergh VWM, ed. Vascular Control of Hemostasis. Ad-vances in Vascular Biology_Vadas MA, Harlan J, series eds.., Vol1. Amsterdam: Harwood Academic Publishers, 19968- Stehouwer CDA. Von Willebrand factor, dysfunction of the vascular endothelium, and the development of renal and vascular complications in diabetes. In: Mogensen CE, ed. The Kidney and Hypertension in Diabetes Mellitus, 3rd edn. Boston: Kluwer, 1997:155– 1639- Stehouwer CDA, Donker AJM. Urinary albumin excretion and cardiovascular disease risk in diabetes mellitus: Is endothelial dysfunction the missing link? J Nephrol 1993;6:72–9210- Vane JR, A° ngg°ard EE, Botting RM. Mechanisms of disease: regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27–36.11- Hamsten A. Hemostatic function and coronary artery disease. N Engl J Med 1995;332:677–67812- Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991;66:351–35513- Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165–116814- Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 1994;89:1573–157915- Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635–64116- Blann AD, Taberner DA. A reliable marker of endothelial dysfunction: does it exist? Br J Haematol 1995;90:244–24817- Waldron JS et al Urine microalbumin excretion in relation to exercise-induced electrocardiographic myocardial ischaemia .Med Sci Monit, 2002; 8(11): CR725-72718- Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–80919- Stehouwer CDA, Donker AJM: Clinical usefulness of measurement of urinary albumin excretion in diabetes mellitus. Neth J Med 42: 175-186, 199320- Severi FM, Bocchi C, Visentin A, Falco P, Cobellis L, Florio P, Zagonari S, Pilu G: Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 19: 225-228, 200221- Kaufmann P, Black S, Huppertz B: Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 69: 1-7, 200322- Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70: 427-451, 199023- Lapillonne A, Peretti N, Ho PS, Claris O, Salle BL: Aetiology, morphology and body composition of infants born small for gestational age. Acta Paediatr Suppl 423: 173-173, 1997 24- Masse J, Forest JC, Moutquin JM: Microalbumin as a marker of premature delivery. Obstet Gynecol 87: 661-663, 199625- Singh H, Samal S, Mahapatro A, Ghose S. Comparison of obstetric outcome in pregnant women with and without microalbuminuria. J Nat Sci Biol Med. 2015 ;6(1):120-426- Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER: Pregnancy outcome in type 1 diabetic women with microalbuminuria.Diabetes Care 24: 1739-1744, 2001 27- Schroder W, Heyl W, Hill-Grasshoff B, Rath W: Clinical value of detecting microalbuminuria as a risk factor for pregnancy-induced hypertension in insulin-treated diabetic pregnancies European Journal of Obstetrics & Gynecology and Reproductive Biology 91: 155-158, 200028- Masse J, Forest JC, Moutquin JM: Microalbumin as a marker of premature delivery. Obstet Gynecol 87: 661-663, 199629- Smith GC, Pell JP, Walsh D: Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.Lancet 357: 2002-2006, 2001